Q1 2025 Evolus Inc Earnings Call Transcript
Key Points
- Evolus Inc (EOLS) reported double-digit revenue growth in the first quarter, achieving a 15.5% increase over the prior year.
- The company gained meaningful market share, outperforming the market and strengthening customer loyalty.
- Evolus Inc (EOLS) successfully launched Evolysse Form and Evolysse Smooth, marking its transition into a multi-product company.
- The company's loyalty program reached a new record with over 220,000 redemptions, indicating high consumer satisfaction and repeat usage.
- Evolus Inc (EOLS) strengthened its financial position by refinancing its debt facility, reducing interest expenses, and increasing cash generation.
- The company reduced its 2025 toxin market growth expectation to low-single-digits due to slower market growth.
- Evolus Inc (EOLS) faced a challenging market backdrop with a decline in the toxin market in the first quarter.
- The company's non-GAAP operating loss in the first quarter was $5.5 million, compared to $0.9 million in Q1 of 2024.
- Evolysse is subject to a 10% tariff, expected to increase to 20%, impacting the company's cost structure.
- The company experienced a decrease in cash, ending the first quarter with $67.9 million compared to $87 million at the end of the fourth quarter.
Good afternoon, everyone. Thank you for standing by. Welcome to Evolus' first-quarter earnings conference call.
As a reminder, today's conference is being recorded and webcast live. (Operator Instructions)
I would now like to turn the conference over to Nareg Sagherian, Vice President, Head of Global Investor Relations and Corporate Communications.
Thank you, operator. Welcome to everyone joining us on today's call to review Evolus' first-quarter financial results.
Our first-quarter press release is now on our website, at evolus.com.
With me, today, are David Moatazedi, President and Chief Executive Officer; and Sandra Beaver, Chief Financial Officer.
Today's call will include forward-looking statements. Actual results may differ, materially, due to risks and uncertainties outlined in our earnings press release and SEC filings. These forward-looking statements are based on current assumptions and we
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
